Alnylam's President Talks Strategy To Become A Top Biotech Company, 'Developing An Entirely New Class Of Medicine'
April 17, 2018 at 11:21 AM EDT
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) is taking on a broad list of indications with RNAi therapeutics, from bleeding disorders to ...